Product Name: Ursoloyl Tripeptide-1
Synonyms: Usnic acid-Tripeptide-1, Usnic acid-GHK, Usnic acid-Gly-His-Lys,
IUPAC Name: ((1S,2R,4aS,6aS,6bR,10S,12aR,12bR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carbonyl)glycyl-L-histidyl-L-lysine,
Description: Ursoloyl Tripeptide-1 is the product obtained by the reaction of Ursolic Acid and Tripeptide-1. snic acid (UA) is a lichen-derived secondary metabolite with a unique dibenzofuran skeleton and is commonly found in lichenized fungi of the genera Usnea and Cladonia. Usnic acid has been incorporated for years in cosmetics, perfumery, and traditional medicines. It has a wide range of bioactivities, including antimicrobial, antiviral, anticancer, anti-inflammatory properties. Ursolic acid and its analogues can be employed to treat various cancers, inflammatory diseases, diabetes, Parkinson’s disease, Alzheimer’s disease, hepatitis B, hepatitis C and AIDS. GHK was isolated in 1973 as an activity bound to human albumin that caused aged human liver tissue to synthesize proteins like younger tissue. GHK peptide has stimulating and growth-promoting effects on many cells and tissues such as chondrocytes, liver cells and human fibroblasts. It increases stemness and stimulates integrin secretion in human epidermal basal keratinocytes, as well as has a strong wound-healing and tissue-repairing effect.